The Federal Trade Commission has reached a landmark settlement with pharmacy benefit manager Express Scripts over allegations it inflated drug prices, particularly for insulin, to boost profits. The ...
A landmark deal aims to end the pricing games that grossly inflate what you pay at the pharmacy.